Renoprotective Effects of Telbivudine in Chronic Hepatitis B
NCT03778567
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B, Chronic
Chronic Kidney Diseases
Interventions
DRUG:
Telbivudine
Sponsor
The University of Hong Kong